Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectBiological Therapies for Cancer: Technologies and Global Markets
The global cancer biologics market should reach $143.0 billion by 2026 from $77.5 billion in 2021 at a compound annual growth rate (CAGR) of 13.0% for the forecast period of 2021 to 2026.
mRNA: Therapeutics and Global Markets
The global market for mRNA therapeutics should grow from $46.7 billion in 2021 to $101.3 billion by 2026, at compound annual growth rate (CAGR) of 16.8% for the period of 2021-2026.
Oligonucleotides: Global Markets to 2026
The global market for oligonucleotide synthesis should grow from $6.1 billion in 2021 to $10.2 billion by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.
Polymerase Chain Reaction (PCR) Technologies and Global Markets
The global market for PCR technology should grow from $10.5 billion in 2021 to $13.7 billion by 2026, at compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026.
DNA Vaccines: Technologies and Global Markets
The global market for DNA vaccines should grow from $3.1 billion in 2021 to $11.5 billion by 2026 with a compound annual growth rate (CAGR) of 30.1% for the period of 2021-2026.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
Autoimmune Disease Diagnostics: Global Markets
The global market for autoimmune disease diagnostics should grow from $13.7 billion in 2021 to $17.0 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA Sequencing should grow from $15.7 billion in 2021 to $37.7 billion by 2026, at compound annual growth rate (CAGR) of 19.1% for the period of 2021-2026.
Global Markets for Enzymes in Industrial Applications
The global market for enzymes in industrial applications should grow from $6.4 billion in 2021 to $8.7 billion by 2026, at compound annual growth rate (CAGR) of 6.3% for the period of 2021-2026.
Soft Tissue Allografts: Global Markets
The global market for soft tissue allografts should grow from $5.1 billion in 2021 to $6.6 billion by 2026, at compound annual growth rate (CAGR) of 5.3% for the period of 2021-2026.
Kinase Inhibitors: Global Markets
The global market for kinase inhibitors should grow from $57.6 billion in 2021 to $79.2 billion by 2026 with a compound annual growth rate (CAGR) of 6.6% for the period of 2021-2026.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells should grow from $2.8 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate (CAGR) of 9.3% for the period of 2021-2026.
Next-generation Sequencing: Emerging Clinical Applications and Gl...
The global market for clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a compound annual growth rate (CAGR) of 31.4% for the period of 2020-2025.
Biosimilars: Global Markets
The global biosimilars market should reach $60.1 billion by 2025 from $15.7 billion in 2020 at a compound annual growth rate (CAGR) of 30.9% for the forecast period of 2020 to 2025.
Global Markets for Research Antibodies
The global market for research antibodies should grow from $2.7 billion in 2020 to $3.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.
Drug Discovery Technologies
The global market for drug discovery technologies should grow from $69.8 billion in 2020 to $110.4 billion by 2025 with a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Ma...
The global market for liquid biopsy should increase from $3.8 billion in 2020 to $19.6 billion by 2025, at a compound annual growth rate (CAGR) of 38.5% during the period of 2020-2025.
Biomarkers: Technologies and Global Markets
The global market for biomarkers should grow from $43.3 billion in 2020 to $92.1 billion by 2025, at compound annual growth rate (CAGR) of 16.3% for the period of 2020-2025.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs should increase from $285.5 billion in 2020 to reach $421.8 billion by 2025, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2020-2025.
Cell Therapy Biomanufacturing: Global Markets
The global market for cell therapy biomanufacturing should grow from $6.5 billion in 2020 to $10.2 billion by 2025, at compound annual growth rate (CAGR) of 9.4% for the period of 2020-2025.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...
The global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics should grow from nearly $3.3 billion in 2020 to $5.0 billion by 2025, at a compound annual growth rate (CAGR) of 9.1% during the period of 2020-2025.
Life Science Tools and Reagents: Global Markets
The global life science tools and diagnostics market should reach $87.3 billion by 2025 from $82.2 billion in 2020 at a compound annual growth rate (CAGR) of 7.7% for the forecast period of 2019 to 2025.
Theranostics: Global Markets
The global market for theranostics should grow from $80.4 billion in 2020 to $129.8 billion by 2025, at compound annual growth rate (CAGR) of 10.1% for the period of 2020-2025.
Artificial Intelligence (AI) in HIV/AIDS
The goal of this short study is to provide a detailed review of how AI is being applied in fighting HIV/AIDS. The report evaluates the utilization of various AI tools (e.g., machine learning, natural language processing, image processing, speech recognition) in diagnosis, therapy, research and development, and health management (e.g., patient data, insurance information, and hospital stay) as it relates to HIV/AIDS. Also, emphasis is given to the types of algorithms (e.g., artificial neural networks, deep learning) that have been developed so far in the field of HIV/AIDS.
Choose your License
Global Markets for Research Antibodies
- An overview of the global market landscape related to the research antibodies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, major reactivities, host species, end-user, and geographical region
- Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
- Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of new discoveries in biological sciences, rapid technological developments in the IVD industry, new antibody technologies and antibody types, and assessment of antibody-based drug discovery and development
- Discussion on advantages and disadvantages of antibody discovery technologies with examples of antibody production, and information on REpAb technology
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global research antibodies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
mRNA: Therapeutics and Global Markets
- An overview of the global market landscape related to the mRNA therapeutics
- In-depth analysis of global market trends, featuring historical revenue data for 2021, 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to mRNA therapeutics, accompanied by a comprehensive market share analysis categorized by therapeutic types, and geographical region
- Coverage of the major developments, pandemic threats, therapeutic developments, and technological developments of the mRNA therapeutics market
- Discussion on significant advantages of mRNA over protein or DNA-based delivery systems and description of demographic and economic trends, and outlook of the mRNA therapeutics market
- Evaluation of current market size and forecast, and information on prophylactic vaccines, vaccine discovery and development, and R&D activities
- Analysis of the various innovative therapeutics as well as new promising vaccines intended for the prevention and treatment of various chronic and infectious diseases
- Assessment of regulatory structure, pricing and reimbursement scenario, and pipeline analysis of the new molecules & therapeutics
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Induced Pluripotent Stem Cells: Global Markets
- An overview of the global market landscape related to the induced pluripotent stem cells
- In-depth analysis of global market trends, featuring historical revenue data for 2021, 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to induced pluripotent stem cells, accompanied by a comprehensive market share analysis categorized by application, method, type, species, products, function, clinical use, and geographical region
- Analysis of the market's dynamics, including growth drivers, inhibitors, and opportunities, and insights into the regulatory environments impacting the market
- Assessment of recent or ongoing research and development activities in the iPSCs segment, highlights of the new developments and the recent pipeline products
- Information on the latest research activities, emerging technologies, and clinical trials
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- An overview of the global market landscape related to the emerging clinical applications of the next-generation sequencing
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to next-generation sequencing, accompanied by a comprehensive market share analysis categorized by disease indication, test complexity, test purpose, application, and geographical region
- Discussion on market opportunities for clinical NGS products, clinical applications, industry structure, regulatory scenario, and penetration of NGS-based diagnostics and technologies within the industry
- Coverage of genome mapping programs, discussion on technological advancements and innovations in sequencing platforms, and information on Ion Torrent Genexus System launched by Thermo Fisher Scientific and Magnis NGS Prep System launched by Agilent Technologies, Inc.
- Description of NGS-oriented tests such as non-invasive prenatal testing (NIPT), and pre-implantation genetic testing (PGT) and discussion on their advantages
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry
Polymerase Chain Reaction (PCR) Technologies and Global Markets
- An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technology, application, and region
- In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
- Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
- Discussion of sustainability trends and factors in emerging materials in the aerospace industry, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
- An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
- Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
- Profiles of the leading global players
3D Cell Cultures: Technologies and Global Markets
- An overview of the global market landscape related to the 3D cell cultures technologies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to 3D cell cultures technologies, accompanied by a comprehensive market share analysis categorized by type, end user, and geographical region
- Information on analytical systems used in tissue and cell culture, cellomics, and human cancer model initiative (HCMI)
- Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
- A look at the main classes of models for researching cancer and other diseases, benefits of 3D models to cancer research and description of 3D engineered scaffolds
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
- Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
- Relevant patent analysis, including recent activity and a list of key patents
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Top Ten Suppliers of Synthetic Biology Technology
- An overview of the global market landscape related to the top ten suppliers of synthetic biology technology
- In-depth analysis of global market trends, featuring historical revenue data for 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to top ten suppliers of synthetic biology technology, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
- Coverage of evolving technologies and highlights of the current and future market potential and a detailed analysis of the regulatory framework and reimbursement scenarios
- Review of patents, product pipeline, ESG trends, and emerging technologies related to synthetic biology
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Life Science Tools and Reagents: Global Markets
- Overview and an up-to-date analysis of the global markets for life sciences tools and reagents
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the market size and revenue forecast for the life science tools and diagnostics market, and corresponding market share analysis based on product type, end user application, and region
- Highlights of the current and future market potential of life science tools and diagnostics, along with a detailed analysis of the competitive environment, regulatory scenario, and technological advances
- In-depth information (facts and figures) pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects, and the impacts of macroeconomic variables
- Assessment of existing products and identification of new potential markets for novel products and assay development
- Discussion on how scientific trends, government policies, and the economy in general affect life sciences tools and diagnostics market and how this industry is different from the pharmaceutical and drug discovery industry
- Overview of the sustainability trends and factors in the life science tools and diagnostics market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
- An analysis of the key patent grants and recent patent publications
- Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activities, and venture funding outlook
- Company profiles of the leading market players
Western Blotting: Global Markets
- An overview of the global market landscape related to the western blotting
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to western blotting, accompanied by a comprehensive market share analysis categorized by product, application, end-user, and geographical region
- Description of concepts like gel electrophoresis and antibody probing, and processes like tissue preparation, protein transfer, blocking and antibody interactions
- Discussion on major application areas of western blotting technique such as disease diagnostics, agriculture, biomedical & biochemical research
- Assessment of processes like protein separations and extraction of target proteins, and introduction of new and innovative imaging platforms such as fluorescent, multiplex, and chemiluminescent western blotting techniques and their protocol
- Coverage of emerging technologies in western blotting market, recent developments, future opportunities, patent review, product pipeline, and ESG trends
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Biologic Therapeutic Drugs: Technologies and Global Markets
- Overview and an up-to-date analysis of the global markets for biologic therapeutic drugs
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the global biologics market, and its corresponding market share analysis based on the product type, therapeutic area, and region
- Discussion of the major factors influencing the growth of this market with respect to opportunities and challenges, upcoming technologies, future demand, regulations, and contributions to the overall market
- Overview of the sustainability trends and factors in the market for biologic therapeutic drugs, with emphasis on consumer attitudes, ESG score analysis, future of ESG, case study, and the ESG practices followed
- Identification of the biopharmaceutical companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Evaluation of the ongoing clinical trials and R&D activities estimating current and future demand for biologics production
- A look at the key marketed drugs and recent approvals, sales statistics and past performance of the top selling biologics, and insight into their patent expiries
- Review of the emerging new technologies and interesting patents on the biologic therapeutic drugs
- An overview of the major vendors along with an analysis of the industry structure, including company market shares, recent mergers and acquisitions, and venture fundings outlook
- Profiles of the leading market players